Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ADIL
ADIAL PHARMACEUTICALS, INC.
NASDAQ
$5.60
▼ DOWN 1.58% (-0.09)

KEY STATISTICS

Market Cap$5.37 M
52w High$10.75
52w Low$1.31
Dividend Yield—
Frequency—
P/E-0.34
Volume63.52K
Shares Out.959.64K

COMPANY

LEADERSHIP

Cary John Claiborne
CHIEF EXECUTIVE
Cary John Claiborne

COMPENSATION 2026

Salary$465,625
Stock Awards$73,314
Incentive Plan Pay$0
All Other Comp.$72,682
Total$801,621

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 27, 2018
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
5

PRICE TARGET

Target High$11.00
Target Low$6.00
Target Median$8.50
Target Consensus$8.50

UPCOMING EARNINGS

DateNov 18, 2026
DayWednesday
Rev. Est.—
NOV
18
WED

SPLIT RECORD

DATETYPERATIO
2026-02-06Reverse1:25
2026-02-05Reverse1:25
2023-08-07Reverse1:25

PRICE

$5.60 ▼ DOWN 1.58% (−$0.09)
OVERLAYS
$5.50$5.60$5.709:30 AM10:35 AM11:39 AM12:44 PM1:49 PM2:53 PM3:58 PM5.60

About Adial Pharmaceuticals, Inc.

https://www.adial.com ↗

Adial Pharmaceuticals, Inc. is a clinical-stage biopharma developing addiction therapeutics, including Phase III AD04 for alcohol use disorder, and other non-opioid pain and disease treatments, based in Charlottesville, VA.

INDUSTRY

Biotechnology

A PRODUCT ADIAL PHARMACEUTICALS, INC. IS KNOWN FOR

AD04
AD04

AD04 is Adial's lead investigational drug, a selective serotonin-3 receptor antagonist in Phase 3 trials, developed to treat Alcohol Use Disorder in genetically responsive patients, using a companion diagnostic test for targeted therapy.

COMPETITORS

COMPETITOR
ALKS COMPARE
BTAI COMPARE
CMND COMPARE
INDV COMPARE
MNOV COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
VXF
0.00% · 5.8K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
100.00%
HOLDERS
31
TOP 12 OF 31 · RANKED BY POSITION SIZE
Armistice Capital, LLC
2.6M sh · $561.98K
Citadel Advisors LLC
219.6K sh · $48.32K
Geode Capital Management, LLC
164.1K sh · $58.02K
Vanguard Group Inc
156.0K sh · $55.23K
Jane Street Group, LLC
121.8K sh · $26.8K
Northern Trust Corp
66.0K sh · $14.52K
Virtu Financial LLC
63.8K sh · $14K
Xtx Topco Ltd
52.1K sh · $11.46K
Manchester Capital Management LLC
48.1K sh · $10.58K
Blackrock Inc.
27.8K sh · $31.93K
Blackrock, Inc.
27.8K sh · $6.11K
Stonex Group Inc.
19.5K sh · $4.28K

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1

INSIDER TRADES

★
10 PERCENT OWNER
Coastlands Capital LP
Purchase · 2.0K shares
2026-07-14
★
10 PERCENT OWNER
Coastlands Capital LP
Purchase · 1.2K shares
2026-07-16
★
10 PERCENT OWNER
Coastlands Capital LP
Purchase · 10.1K shares
2026-07-09
★
10 PERCENT OWNER
Coastlands Capital LP
Purchase · 1.7K shares
2026-07-10

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
Maxim Group BUY

SECTORS PEERS

PEERPRICE
BCDA$1.15COMPARE
NRSN$0.42COMPARE
BCLI$1.12COMPARE
KPRX$2.62COMPARE
APRE$0.84COMPARE
ACXP$1.44COMPARE
CDIO$1.85COMPARE
CELZ$1.14COMPARE